dMax, a naturally occurring splice variant of the Myc binding protein Max, lacks the DNA binding basic region and helix 1 of the Helix ± Loop ± Helix domain; dMax interacts with c-Myc in vitro and in vivo, and inhibits E-box Myc site driven transcription in transient transfection assays. Here we have investigated the expression, function and interactions of dMax. RT/ PCR analyses detected dmax mRNA in multiple tissues of the developing, newborn and adult mouse. Functionally, dMax reduced the ability of c-Myc to cooperate with the progression factor A-Myb to promote S phase entry of quiescent smooth muscle cells. In contrast, dMax failed to ablate inhibition of initiator element (Inr)-mediated transcription by c-Myc in Jurkat T cells. In in vitro protein : protein association assays, dMax interacted with c-Myc, N-Myc, L-Myc, Mad1, Mxi1, Mad3 and Mad4, but not with itself or wild-type Max. These interactions required an intact leucine zipper. Inhibition of E-box-mediated transactivation by induction of dMax overexpression resulted in apoptosis of WEHI 231 B cells. Thus, dMax is a widely expressed, naturally occurring protein, with the capacity to bind most members of the Myc/Max superfamily; dMax has little eect on Inr-mediated repression by c-Myc, but can signi®cantly decrease E-box-mediated events promoting proliferation and cell survival.
Introduction
The c-Myc proto-oncoprotein plays a key role in cell growth regulation. Some of the earliest evidence regarding the role of c-Myc in cell proliferation was the observation that it is expressed at low levels in untransformed cells, with a large increase occurring during the G 0 to G 1 transition (Campisi et al., 1984; Kelly et al., 1983) . Furthermore, enforced expression or microinjection of c-Myc protein relieved quiescent ®broblasts of the requirement for platelet-derived growth factor for proliferation, and sensitized them to the mitogenic eects of epidermal growth factor (Armelin et al., 1984; Kaczmarek et al., 1985) . Using antisense oligonucleotides, inhibition of c-Myc expression was shown to interfere with entry into S phase (Heikkila et al., 1987; Holt et al., 1988) . This and subsequent evidence on gene expression (Bello-Fernandez et al., 1993; Galaktionov et al., 1996) led to the model that c-Myc is a factor which promotes proliferative competence.
Max (Myc associated factor x) was originally isolated as a protein that bound to c-Myc (Blackwood and Eisenman, 1991) . It has been shown to interact with the other members of the Myc family, Nand L-Myc (Blackwood and Eisenman, 1991; Wenzel et al., 1991) . Max is characterized by the presence of three closely linked functional domains, a basic region (b), and helix ± loop ± helix (HLH), and leucine zipper (LZ) motifs. The HLH and LZ motifs together mediate speci®c protein : protein interactions of Max with itself and with other bHLH/LZ family members, and the basic region facilitates DNA binding of the dimerized factors to the E-box DNA sequence CACGTG (Amati et al., 1992; Berberich et al., 1992; Blackwood and Eisenman, 1991; Crouch et al., 1993; Davis and Halazonetis, 1993; Henriksson and Luscher, 1996; Kato et al., 1992; Reddy et al., 1992) .
In addition to a carboxyl-terminal b/HLH/LZ domain which mediates its interaction with Max and with DNA, the c-Myc protein bears an amino-terminal transactivation domain encompassing amino acid (AA) 1 ± 143 (Amati et al., 1992; Blackwell et al., 1990; Blackwood et al., 1992; Blackwood and Eisenman, 1991; Crouch et al., 1993; Kato et al., 1990 Kato et al., , 1992 . Unlike Max, c-Myc does not form DNA-binding competent homodimers at physiological protein concentrations. Rather, c-Myc requires heterodimer formation with Max to speci®cally bind the E-box DNA sequence (Amati et al., 1992) . Proposed c-Myc target genes include those encoding ornithine decarboxylase (ODC) (Bello-Fernandez and Cleveland, 1992; Bello-Fernandez et al., 1993) and the CDK-activating phosphatase cdc25A (Galaktionov et al., 1996) , both of which are expressed in the mid G 1 phase of the cell cycle and are critically important for cell proliferation. As the Myc-responsiveness of both of these growthrelated genes requires intact intronic E-box elements (Bello-Fernandez et al., 1993; Galaktionov et al., 1996) , the growth-promoting role of c-Myc likely depends upon E-box transactivation.
More recently, c-Myc was shown to repress transcription from genes containing initiator (Inr) elements within their promoters (Li et al., 1994; Roy et al., 1993) . Inr elements were originally de®ned from a loose consensus 5'-YYCAYYYYY-3' found at the transcription initiation sites of genes containing upstream TATA elements (Grossschedl and Birnstiel, 1980; Smale and Baltimore, 1989) . Subsequently, a number of genes lacking a TATA box were found to have Inr elements which were required to direct proper assembly of a transcriptional pre-initiation complex (Smale and Baltimore, 1989) . Originally discovered acting on the Adenovirus Major Late (AdML) promoter, and later on the dierentiation-speci®c l5, TdT, albumin, and C/EBPa promoters, c-Myc repressive activity via Inr elements was found to require the Myc homology box II region encompassed within AA 106 ± 143 Li et al., 1994; Mai and Martensson, 1995) .
We have recently described the isolation and cloning of a naturally-occurring dominant inhibitory version of Max, termed dMax . This protein is a splice variant of Max that lacks the basic region, helix 1, and the loop of the HLH motif. The resulting dMax product was shown to interact with c-Myc protein both in vitro and in vivo, and to repress c-Mycmediated, E-box-driven transactivation in NIH3T3 cells . Here we have examined the expression and functional roles of dMax. We show that dMax is widely expressed and has no eect on cMyc repression through Inr elements; dMax can inhibit the proliferative competence-promoting role of c-Myc and induce apoptosis of WEHI 231 B cells. Thus, dMax selectively decreases E-box-mediated events involved in promoting cell proliferation and cell survival.
Results

dMax is widely expressed in tissues of the developing and adult mouse
Spatial and temporal expression of Myc family members is a hallmark of mammalian development (Zimmerman et al., 1986) . To determine the pattern of dMax expression during normal development, we have examined total RNA isolated from tissues of embryonic, newborn, and adult mice for expression of dmax mRNA. Because there are multiple max bands detected by Northern blot hybridization analyses (Berberich et al., 1992 , and data not shown), we performed semi-quantitative reverse transcription PCR analysis using a 5' primer which spans the splice junction of the dmax mRNA, and thus only allows ampli®cation of the splice variant (Figure 1 ). These analyses indicate that the alternatively spliced dmax mRNA is widely expressed in the developing embryo, newborn and adult mouse. For comparison, we analysed samples of the same RNA preparations for expression of wild-type (wt) max and c-myc mRNAs using the RT ± PCR approach. In agreement with previous studies (Berberich et al., 1992; Blackwood et al., 1992; Wagner et al., 1992) , max mRNA was detected in every tissue analysed. Also in accord with other studies (Schmid et al., 1989; Semsei et al., 1989; Zimmerman et al., 1986) , c-myc mRNA was detectable in all tissues and all stages of development examined, but was dramatically more abundant in the rapidly proliferating fetal tissues than in newborn or adult tissues. RT ± PCR analysis performed using primers speci®c for GAPDH mRNA provided a measure of the integrity and quantitation of the RNA samples used. The widespread expression of dmax mRNA suggests that dMax might have a signi®cant impact on functional c-Myc activity during development.
dMax inhibits the competence-promoting role of c-Myc in SMCs
Because we had previously shown that dMax associates with c-Myc in vivo and could inhibit E-box-driven transcription in transient transfection assays , we wished to determine whether dMax could functionally in¯uence c-Myc-mediated eects on cell proliferation. Recently, we have shown that microinjection of serum-deprived SMCs with expression plasmids encoding either c-Myc or the cell cycle progression factor A-Myb alone had only modest eects on DNA synthesis, while co-microinjection of c-Myc and A-Myb vectors led to synergistic and potent stimulation of [ 3 H]thymidine incorporation (Marhamati et al., 1997) . Primary bovine SMCs were used in a microinjection-based assay to test for the eects of dMax on the competence-promoting activity of c-Myc. Quiescent SMCs were microinjected with vectors expressing A-Myb alone, or A-Myb and c-Myc, or A-Myb and c-Myc in the presence of GST-dMax protein or GST protein, as control. Cells were labeled with 3 H-thymidine for 20 h. A-Myb alone yielded no signi®cant change in nuclear labeling relative to noninjected cells as measured by autoradiography ( Figure  2 ). As expected, co-microinjection with A-Myb and cMyc vectors led to an approximately sevenfold increase in 3 H-thymidine incorporation, with approximately 70% of nuclei becoming labeled. When GST-dMax protein was co-microinjected with the same doses of AMyb and c-Myc vectors, the labeling fell dramatically, Figure 1 Analysis of dMax mRNA expression in developing and adult mouse tissues. 1 mg of total RNA isolated from the indicated tissues (fetal RNA samples were isolated at 12.5 and 15.5 days of gestation from head (H) or trunk (T); Int., intestine) was reverse-transcribed using random hexamer primers and reverse transcriptase. Aliquots of these reactions were subjected to [ 32 P]dATP-supplemented polymerase chain reactions using primers speci®c for dMax (results of two separate assays shown for comparison), wt max, c-myc and GAPDH as described in Materials and methods. Aliquots of each reaction were electrophoresed on 16TBE, 5% polyacrylamide gels, dried and exposed to X-ray ®lm almost to the level seen with A-Myb alone. In contrast, GST protein had essentially no eect on the ability of c-Myc and A-Myb to induce entry into S phase. Lastly, the eects of mutation of the dMax LZ domain were assessed. Co-microinjection of dMax fusion protein, with an altered LZ such that interaction with c-Myc protein is severely ablated (see below), also did not signi®cantly inhibit entry into S phase. Thus, dMax interfered with the well-documented competence promoting function of c-Myc.
dMax does not in¯uence c-Myc repression of Inr-mediated transcription
To examine whether dMax could similarly in¯uence cMyc repression of Inr-mediated gene transcription, the vector pMLI 1 , which bears Adenovirus major late promoter-derived sequences linked to CAT coding sequences, was used. Inr-dependent expression from the Adenovirus sequences had been established by deletion of the adjoining TATA element, as demonstrated by Du et al. (1993) . To ®rst establish that this construct was sensitive to c-Myc inhibition the Jurkat T cell line was chosen due to its relatively high baseline expression of Inr-driven reporter constructs (ManzanoWinkler et al., 1996) , and its relatively low c-Myc expression levels. Cells were transfected with either pMLI 1 (containing two wt Inr elements), or pMLI 1 R 2 , the latter bearing mutations in both Inr consensus elements. Analysis of cell extracts for CAT activity indicated that pMLI 1 directed approximately three times more CAT expression than did the mutated pMLI 1 R 2 construct, indicating that expression from the wt construct was indeed Inr-speci®c in these cells (Figure 3a) . Upon co-transfection of the Inr reporters with a CMV promoter-driven c-Myc expression Figure 2 Eects of dMax on c-Myc-dependent entry of quiescent SMCs into S phase. SMC cultures, plated at 3000 cells/mm 2 , were rendered quiescent via serum deprivation for 48 h. All cells within a de®ned grid (between 65 and 152 cells per sample) were microinjected with the indicated vectors: 500 mg/ml A-Myb expression vector pCA1 or c-Myc expression vector pM21. pBluescript DNA was included to bring ®nal DNA concentration to 1 mg/ml where needed. GST-dMax, GST-FRLZ or GST protein was co-injected at 1 mg/ml where indicated. Following microinjection, cells were washed extensively and incubated in medium containing 0.5% FBS and 2 mCi of [ 3 H]-thymidine per ml. After 20 h, the cells were ®xed and processed for autoradiography as previously described (Marhamati et al., 1997) construct, the activity of pMLI 1 was reduced essentially to the level of expression driven by the mutant Inr construct alone. In contrast, c-Myc co-expression had an insigni®cant eect on expression directed by the pMLI 1 R 2 construct ( Figure 3a) . Thus, c-Myc essentially completely inhibited the Inr-directed transcription of pMLI 1 in Jurkat cells.
To determine whether dMax in¯uences Inr-mediated transcription, Jurkat cells were co-transfected with pMLI 1 and increasing doses of a dMax expression vector in the absence or presence of a suboptimal dose of c-Myc expression vector. As noted above, c-Myc signi®cantly repressed the activity of the Inr reporter vector (Figure 3b ). In contrast, co-transfection with dMax at either dose had no eect on the level of repression by c-Myc. Furthermore, co-transfection with dMax alone had no signi®cant eect on expression from the pMLI 1 construct. Taken together, these ®ndings imply that dMax has a dierential eect on c-Myc pathways. While having no signi®cant eect on c-Myc repression through Inr elements, dMax potently inhibited the positive transactivation through E-box.
dMax associates with other Max binding partners
Because dMax appears to have a selective eect on Ebox-driven transcription, we asked whether dMax could associate with other members of the Myc/Max/ Mad/Mxi family also shown to in¯uence transactivation of E-box genes. In vitro protein : protein association assays were performed using a GST-dMax fusion protein and various 35 S-labeled candidate binding partners, the latter generated by cell-free transcription and translation. For each protein assayed, an equivalent aliquot of the labeled cell-free translation reaction was electrophoresed alongside a sample which had been incubated with GST-dMax and GSHSepharose and extensively washed prior to electrophoresis (Figures 4 and 5) . Values for the percentage of labeled protein in the pulled down band compared to the appropriate total in vitro translation product were calculated as described in the Materials and methods. Family members which positively in¯uence E-box transactivation (e.g. c-, N-and L-Myc), as well as those reported to inhibit E-box transactivation (Mad1: Mxi1: Zervos et al., 1993; Mad3 and Mad4: Hurlin et al., 1995) have been analysed. As expected, labeled c-Myc interacted eciently with GST-dMax (Figure 4 , lane 2 and Table 1 ), con®rming both our previous observation of GST-Myc : dMax interaction and the integrity of the GST-dMax preparation used. As a control for the speci®city of binding, each labeled protein was reacted with wt GST protein ( (Table 1) . Because wt Max readily forms homodimers, we also assessed the ability of GST-dMax to interact with labeled dMax or labeled Max. Interestingly, neither homodimerization (lane 12), nor heterodimerization with wt Max (lane 16) was detected under these conditions (Figure 4 ). Densitometry of this data indicated that less than 1% of the total radiolabeled dMax or Max protein (approximately 0.8 and 0.5%, respectively) interacted with dMax. As expected, the wt Max preparation used was capable of homodimer formation (Figure 4 , lane 17), but was again unable to form heterodimers with radiolabeled dMax (Figure 4 , lane 13). The failure of dMax to homodimerize or heterodimerize with wt Max probably relates to the loss of the ®rst helix and loop S-labeled in vitro translation reactions programmed with in vitro-transcribed mRNAs encoding the indicated proteins was incubated with 500 ng of either GST-dMax (lanes 2, 6, 12 and 16) or GST-Max (lanes 3, 7, 13 and 17) and GSH-Sepharose, followed by extensive washing. Bound proteins were electrophoresed next to 1 ml aliquots of the corresponding in vitro translation reaction (lanes 1, 5, 11 and 15) on 12% polyacrylamide SDS gels, and the resulting auto¯uorogram exposed to X-ray ®lm. For analysis of L-Myc, 500 ng of GST-L-Myc were incubated with 1 ml of 35 Slabeled dMax or Max in vitro translation reactions, followed by treatment similar to other samples (lanes 9 and 10, respectively). b, endogenous b-globin generated in the rabbit reticulocyte in vitro translation system. *indicates migration of unincorporated [ 35 S]Met of the HLH domain (Reddy et al., 1992) , and may have important functional consequences, in that the amount of dMax available for interactions with other superfamily proteins would not be diminished by selfcompetition. The interaction of dMax with Mad/Mxi family members is intriguing in that both dMax and Mad proteins have negative in¯uences on E-box-driven transcription. These ®ndings suggest dMax has the potential to modify not only the activities of factors positively aecting the E-box pathway, but also the activities of the repressive Mad/Mxi family factors.
To examine possible dierences in the ability of partner proteins to interact with dMax versus wt Max, parallel association assays were performed with a similar amount of a GST-Max preparation (Figure 4 , lanes 3, 7, 10, 13 and 17; Figure 5 , lanes 3, 7, 11 and 15). Comparison of the amounts of radiolabeled species precipitated by the two dierent GST fusion proteins indicated that dMax binds the potential partner proteins nearly as eciently as Max, if not slightly more so, with all partners tested (Table 1) , except dMax and wt Max which were at or below background GST levels. While there are minor dierences in binding eciencies between dMax and Max for the partner proteins tested, it is clear that dMax has the potential to interact with all Max partner proteins at physiologically relevant relative concentrations.
The alternative splicing of dMax RNA leaves the LZ domain as the only intact known protein interaction motif in the dMax protein, leading us to predict that the LZ mediates the observed protein associations. To test this possibility, several GST-Myc fusion proteins, including a full-length wt Myc fusion, and LZ and HLH deletion mutants were used in interaction assays with in vitro 35 S-labeled dMax protein. Essentially no dMax binding activity was seen with the c-MycDLZ deletion mutant, while the DHLH mutant exhibited signi®cant binding, albeit at a reduced level relative to wt Myc (Figure 6a , lanes 2 ± 4). This reduction is most likely observed because the HLH motif is immediately adjacent to the LZ domain, and the gross deletion has altered the protein conformation about the LZ. To more carefully ascertain the role of the LZ in dMax protein interactions, we prepared a mutant GST-dMax protein, termed dMax ± FRLZ, in which the internal two leucine residues were altered by single-base mutations to Phe and Arg, respectively. When tested in protein : protein association assays, the FRLZ mutant protein bound c-Myc over tenfold less eciently than wt dMax (2.8% versus 31% of input 35 S-Myc bound, respectively; Figure 6b, lanes 2 and 3) . Similarly, Mad1 (lanes 6 and 7), and N-Myc (lanes 10 and 11), showed greater than tenfold and over 25-fold higher binding to dMax than dMax ± FRLZ, respectively (Figure 6b ). These ®ndings indicate that the LZ is the major structural determinant governing dMax heterodimerization activity.
dMax induces apoptosis in WEHI 231 cells WEHI 231 B cells are a commonly used paradigm for studying control of cell suicide (Thompson, 1998) . Cross linking of surface IgM on these immature B cells with speci®c antibodies leads to apoptosis. We have recently shown that a key event in this process is a decrease in c-Myc levels, and that maintaining a high c-Myc level through constitutive expression from an exogenous construct rescues these cells from receptormediated apoptosis . To examine the in¯uence of dMax on inhibition of E-box function, WEHI 231 cells were stably transfected with an IPTGinducible dMax expression construct, and analysed for induction of apoptosis. Two separately selected pools of cells, designated dMaxLS-1 and dMaxLS-2, were examined in detail following a 20 h incubation with IPTG. In the dMaxLS-1 population, a moderate baseline amount of dMax was detected, which was dramatically induced by IPTG treatment (Figure 7a ). In the dMaxLS-2 population, a somewhat elevated baseline of dMax was detected, which was more moderately induced upon treatment (Figure 7a ). To quantitate cell death via apoptosis, FACS analysis was performed on propidium iodide-stained cells, with dying cells exhibiting¯uorescence indicative of less than 2N DNA content. The level of apoptosis in both pools of dMax-transfected cells was higher before IPTG treatment than in non-treated control cells expressing only the lac repressor protein (Figure 7b ). In particular, dMaxLS-2, which exhibited the highest basal expression of dMax, had nearly three times the proportion of apoptotic cells seen in the control cultures. IPTG treatment of both dMax-expressing populations markedly increased the percentage of apoptotic cells over that seen in untreated cultures. For the dMaxLS-1 pool, treatment with IPTG for 20 h induced a fourfold increase in apoptotic cells. Treatment of dMaxLS-2 cells resulted in an approximately twofold increase of apoptotic cells over the high basal levels observed in untreated cell cultures. In contrast, IPTG treatment of cells transfected only with the Lac repressor induced no signi®cant increase in apoptotic cells (Figure 7b ). Both the baseline levels of dMax and the diering degrees to which IPTG induced expression correlated very well with the level of apoptosis. Thus, in the absence of other signals, activation of dMax protein expression induces Cells stably expressing the lac repressor alone (3'ss), or the lac repressor plus the IPTG-inducible dMax vector ((dMaxLS-1), and (dMaxLS-2)) were stained with propidium iodide and subjected to FACS analyses. M1 indicates the position of cells (of 5000 events) exhibiting¯uorescence indicative of less than 2N DNA content. Cells in the left-hand column were incubated in normal medium (-IPTG), while those in the right-hand column were treated with 20 mM IPTG prior to staining and FACS analysis apoptosis of WEHI 231 cells, presumably via reduction in E-box-mediated transactivation.
Discussion
Here we show that the dominant negative dMax protein, encoded by an alternatively spliced max transcript, is widely expressed and selectively dampens E-box mediated events, yet has little eect on the ability of c-Myc to repress transcription through an Inr-element. The dMax transcript was detected in diverse developing and adult mouse tissues. Previously, transfection analysis demonstrated the ability of dMax to inhibit E-box mediated transactivation in 3T3 cells . Here we further show that dMax ablates the ability of c-Myc to cooperate with the progression factor A-Myb to promote entry of quiescent smooth muscle cells into S phase. As expected, dMax inhibited transactivation of an Ebox-containing ODC promoter/exon 1 reporter construct in transiently transfected SMC cultures (data not shown), consistent with the c-Myc competence function relying upon E-box transactivation in SMCs. The interaction of c-Myc with dMax, which lacks the ®rst helix and loop of the HLH region, was found to be mediated through the intact LZ within dMax protein.
In addition, we observed that inhibition of E-box transactivation upon overexpression of dMax induced apoptosis of WEHI 231 B cells, consistent with our previous work indicating c-Myc provides survival signals in these cells . In vitro binding assays demonstrated interaction of dMax with positive E-box transactivators (such as c-Myc, N-Myc and LMyc), as well as with many negative regulating proteins of the Mad/Mxi family. In contrast, dMax did not bind Max. An increase in dMax should, therefore, lead to an increase in binding of Max relative to these Myc/ Mad/Mxi proteins. Thus, dMax has the capacity to selectively down-modulate or dampen the ability of Myc and Mad/Mxi family members to either positively or negatively regulate expression of genes containing Ebox elements. Our ®ndings implicate the selective modulation of pathways involving expression of Ebox-regulated genes by dMax in mediating control of cell proliferation and cell death.
Interestingly, dMax expression was relatively constant from fetal to adult tissues. This is in contrast with c-Myc, which is strongly expressed in tissues of developing embryos but dramatically down-regulated in newborn and adult tissues (Zimmerman et al., 1986) . This has several important implications. First, the ratio of dMax to c-Myc increases dramatically from development through adulthood. Thus, in the developing embryos one might expect the negative impact of dMax on c-Myc-driven processes would be small relative to its impact in the newborn or the adult. As discussed above, many of the E-box-containing genes identi®ed to be regulated by c-Myc have been implicated in promoting cell proliferation, such as the genes for ODC (Bello-Fernandez and Cleveland, 1992; Bello-Fernandez et al., 1993) , prothymosin a (Eilers et al., 1991; Gaubatz et al., 1994) , and Cdc 25 (Galaktionov et al., 1996) . In contrast, Inr-regulated genes tend to be involved in growth inhibition and/or the fully dierentiated cell phenotype, such as the genes for C/EBP a (Li et al., 1994) , albumin (Li et al., 1994) , TdT (Mai and Martensson, 1995) , l5 (Mai and Martensson, 1995) and MHC class I genes (Koller and Orr, 1985; Li et al., 1994; Tibensky and Delovitch, 1990 ). One might expect, then, that the high c-Myc/ dMax ratio in embryonic tissues would allow for both activation of growth promoting (E-box) genes and repression of growth inhibitory (Inr) genes. At later times, when the c-Myc/dMax ratio is low, the amount of dMax may be sucient to block E-box transactivation, as seen previously ; furthermore, the overall drop in c-Myc expression would promote derepression of Inr activity, contributing to growth inhibition and/or expression of the dierentiated phenotype. Lastly, Max has recently emerged as a central ®gure in a network of additional binding partners, including Mad1, Mxi1, Mad3, and Mad4 Hurlin et al., 1995; Schreiber-Agus et al., 1995; Zervos et al., 1993) . While the exact functional roles of these factors remain to be elucidated, members of the family have been implicated in regulating processes of dierentiation, cell proliferation, and neoplastic transformation (Hurlin et al., 1995; Larsson et al., 1994; Roussel et al., 1996; Schreiber-Agus et al., 1995; Vastrik et al., 1995) . The widespread pattern of dMax expression suggests it may add another layer of complexity of the Myc/Max/Mad/Mxi family signalling pathways.
Activation of dMax expression from an inducible promoter caused apoptosis in WEHI 231 cells in the absence of other signals. Because exponentially growing WEHI 231 cells express endogenous dMax, it appears that the apoptotic mechanism in these cells is sensitive to the amount of dMax present, rather than to its absolute presence or absence. This is consistent with the diering levels of apoptosis observed in the two dierent pools of transfected cells examined here. High induced levels corresponded to high apoptotic indices, and elevated uninduced levels also correlated with elevated baseline apoptosis. Thus, inhibition of Ebox mediated transactivation via induction of dMax levels or microinjection of the inhibitory Mad1 protein, as shown previously , is sucient to induce apoptosis of WEHI 231 cells; although the Ebox regulated genes that are inhibited in WEHI 231 cells by these treatments remain to be determined. The ability of wt Max to promote apoptosis was noted recently by Zhang et al. (1997) , who found that overexpression of the longer alternatively spliced (p22) form of Max in NIH3T3 cells reduced transiently transfected or endogenous c-Myc E-box responsive gene expression, slowed growth, and accelerated apoptosis following growth factor deprivation. It remains to be determined whether dMax ablates the enhanced level of apoptosis induced upon deprivation of a critical growth factor in various cells overexpressing c-Myc (Thompson, 1998) .
Previously, we have demonstrated that c-Myc expression promotes survival of WEHI 231 B cells, preventing apoptosis induced upon treatment with anti-IgM or TGF-b1 Wu et al., 1996) . Interestingly, our recent evidence indicates that during apoptosis of WEHI 231 cells induced by these agents, the expression of several E-box-containing genes shown elsewhere to be regulated by c-Myc do not undergo changes concomitant with the alterations in c-Myc levels (data not shown). These ®ndings may re¯ect the high constitutive level of dMax expression noted in these cells . Given the results presented here, the intriguing possibility is raised that c-Myc may be responsible for repression of genes not only involved in control of dierentiation but also instrumental in promoting growth arrest and apoptosis in WEHI 231 cells. Thus, one can hypothesize that the drop in the level of c-Myc leads to derepression of pro-apoptotic genes; this model is currently under investigation.
Materials and methods
Cell culture conditions
WEHI 231 cells were maintained as described previously (Lee et al., 1995; Maheswaran et al., 1994) in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 0.35% glucose, 0.058% glutamine, non-essential amino acids (Life Technologies), 100 units per ml penicillin, 100 mg per ml streptomycin and 50 mM b-mercaptoethanol (complete medium). The Jurkat T cell line was maintained in DMEM supplemented with 10% FBS, glutamine, non essential amino acids, penicillin, and streptomycin. Primary bovine aortic smooth muscle cells (SMC) were maintained and synchronized as described previously (Marhamati et al., 1997) .
Reverse transcription PCR
For speci®c detection of dMax mRNA, the oligonucleotide 5'-GTTTCAATCTGCGGCATC-3', which spans the alternate splice junction (corresponding to nucleotides 51 ± 63 and 172 ± 176 of the wt max gene where the sequence 3' of the splice junction is underlined) was used as the 5' primer and the oligonucleotide 5'-AGGAGAGCCTGGTAGAG-CAGGCGT-3' (the complement of wt max nucleotides 836 ± 859) was used as the 3' primer. This primer combination failed to yield an ampli®cation product when a wt Max-encoding plasmid was used as template (data not shown). For detection of wt max mRNA, the oligonucleotide 5'-ATGAGCGATAACGATGACATCGAG-3' (nucleotides 1 ± 24 of the wt max coding sequence) was used as the 5' primer, with the same 3' primer listed above. Cmyc mRNA was detected using the 5' primer 5'-AGGAACTATGACCTCGACTACGAC-3'
(nucleotides 634 ± 657 of the mouse c-myc gene, relative to the c-myc P1 transcription start site) and the 3' primer 5'-ACGTGGCACCTCTTGAGGACCAGT-3' (the complement of nucleotides 1459 ± 1482). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was detected using the 5' primer 5'-CCATCACCATCTTCCAGGAG-3' (nucleotides 258 ± 277 of the murine gene) and the 3' primer 5'-CCTGCTTCACCACCTTCTTG-3' (the complement of nucleotides 833 ± 814). Embryo staging and total RNA isolation were performed as described (Auray and Rougeon, 1980; Hatton et al., 1996) . Reverse transcription (RT) reactions contained 5 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM random hexamers (Promega), 1 mM each deoxynucleoside triphosphate (dNTP), 1 unit of placental ribonuclease inhibitor, 2.5 units of MMLV reverse transcriptase per ml and 1 mg of total RNA template. PCR was performed using aliquots (2 ml) of each RT sample in reactions containing 2 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 0.2 mM each dNTP, 2.5 mCi of [ 32 P]dCTP (3000 Ci/mMol, NEN DuPont), 0.025 units per ml Taq polymerase (Life Technologies), and 3.75 pMol of each primer in a ®nal volume of 25 ml. Reactions were incubated for 1 min at 948C, followed by cycles of 30 s at 948C, 1 min at 608C and 1 min at 728C. Using these conditions, 22 PCR cycles were within the linear range of ampli®cation for all target genes examined. Samples were electrophoresed on 6% nondenaturing polyacrylamide, 16TAE (40 mM Tris-acetate (pH 8.0), 1 mM EDTA) gels, dried, and exposed to Kodak X-AR ®lm.
Preparation of plasmid constructs and generation of stable transfectants pGST-dMax was generated by removal of the entire insert of pTA-dMax by EcoRV and BamHI digestion and blunt-end ligation into the SmaI site of pGEX-3X after the BamHI overhangs had been ®lled in using the large fragment of E. coli DNA polymerase.
The double site-directed leucine zipper mutant pGST-FRLZ-dMax was generated through PCR using the mutagenic primers 5'-GACTTCAAGCGGCAGAAT-GCTCTTCGGGAGC-3' (`sense') and 5'-GCTCCCGAA-CCGCTTGAAGTC-3' (`antisense'), in which the underlined nucleotides change the central two leucines of the LZ to phenylalanine and arginine, respectively. These primers were used in conjunction with primers 5'-dMax (5'-CGATCC-CATCTGCAGAATTCG-3') and 3'-dMax (5'-GCC-AGTGTGCTGGAATTCGGC-3'), which¯ank the dMax coding sequence in pGST-dMax and encompass EcoRI sites, to generate 5' and 3' mutagenized PCR fragments. These fragments were mixed, denatured and allowed to anneal. The annealed fragments were employed as template in a PCR reaction using only the 5'-dMax and 3'-dMax primers. The resulting fragment was digested with EcoRI and ligated to EcoRi-digested pGEX-3X to generate pGST-FRLZ-dMax. The mutations were veri®ed by DNA sequencing.
To generate the Isopropyl-b-D-thiogalactopyranoside (IPTG, Life Technologies)-inducible dMax construct pdMaxLS, the vector pOPRSVICAT (Stratagene) was digested with NotI to remove the CAT gene cassette. The NotI overhangs were ®lled in with the large fragment of E. coli DNA polymerase and dNTPs, and the resulting DNA was ligated to the EcoRI fragment of pTA-dMax, which had been treated similarly to create blunt ends. The orientation of the insert was con®rmed by restriction mapping. For transfections, WEHI 231 cells were ®rst transfected with the Lac repressor plasmid p3'ss (Stratagene) by electroporation as described , followed by selection for stable integration in medium containing 400 mg Hygromycin B (Boehringer Mannheim) per ml. Pooled transfected cells stably expressing the Lac repressor were then similarly transfected with the pdMaxLS construct and selected in medium containing 400 mg Hygromycin B and 1 mg active Geneticin (G418, Sigma) per ml for 14 days. Two separate pools of stable double transfectants were generated, termed (WEHI) dMaxLS-1 and dMaxLS-2. Transfected pools of cells were maintained in RPMI 1640 complete medium containing 20% fetal bovine serum, and 1 mg G418, and 400 mg Hygromycin B per ml. For induction of dMax expression, IPTG was added to a ®nal concentration of 20 mM.
Microinjection
Microinjection of quiescent SMCs and subsequent assay for [ 3 H]thymidine incorporation was performed according to the method used in Marhamati et al. (1997) . Expression plasmids pM21 (encoding full length human c-Myc driven by the Moloney murine leukemia virus long terminal repeat) and pCA1 A-Myb (encoding full length human A-Myb driven by the SV40 early promoter) were also as described (Marhamati et al., 1997) . GST, GST-dMax, and GST-dMax-FRLZ proteins were prepared according to Frangioni and Neel (1993) , followed by dialysis against PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 176 mM KH 2 PO 4 , pH 7.4), 10% glycerol. Proteins prepared in this manner were then concentrated using Ultrafree CL ®lters (Millipore) to a ®nal concentration of 1 mg/ml before microinjection.
Transient transfection analyses
Chloramphenicol acetyltransferase (CAT) reporter gene constructs driven by the Adenovirus major late promoter Inrs were as described by Du et al. (1993) . Speci®cally, the constructs pMLI 1 and pMLI 1 RI 2 contain either wt or mutated versions, respectively, of the Inr1 and Inr2 elements. The pRc-CMV-Myc expression vector expresses human Myc2 protein, the predominant form initiated from the AUG codon start site, under the control of the cytomegalovirus promoter (Hann et al., 1994) . The dMax expression vector pMT2T-dMax was described previously . For transfection, exponentially growing Jurkat T cells were washed once with fresh medium and resuspended in DMEM supplemented with 20% FBS at a concentration of 2610 7 cells/ml. Each transfected sample contained 40 mg of DNA, normalized using wt pMT2T vector DNA (for pMT2T-dMax-containing samples) and pBluescript DNA. Cells (250 ml) were preincubated with DNA for 10 min on ice, followed by electroporation at 240 V and 960 mF using a Gene Pulser apparatus (Bio-Rad Laboratories). Subsequently, cell suspensions were incubated on ice for 5 min, 1.75 ml of 10% FBS-containing medium was added and cells were incubated at room temperature for 10 min. The electroporated cells were transferred to petri dishes and incubated at 378C, 5% CO 2 for 12 ± 20 h. Cell extracts were prepared by freeze/thaw lysis and equal amounts of protein (assayed using the Bio-Rad D c protein quantitation kit) were analysed for CAT activity essentially as described (Lee et al., 1995) .
Protein : protein association studies
Glutathione-S-transferase (GST) or fusion proteins of GST with potential dMax binding partners were prepared as described (Frangioni and Neel, 1993) . Protein preparations were dialyzed against PBS, 10% glycerol and stored frozen in aliquots at 7808C until use.
For cell-free protein synthesis, mRNAs were synthesized using 1 mg of the appropriate linearized plasmid template and the mCap mRNA Synthesis Kit (Stratagene), according to the manufacturer's instructions.
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S-labeled proteins were synthesized using 0.5 mg of synthetic mRNA, and 1 mCi/ml [ Max expression plasmids used were as described .
For association studies, 1 ml of labeled in vitro translation reaction was added to 20 ml of NETN (100 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl (pH 8.0), 0.5% Nonidet P-40) containing 500 ng of the appropriate GST fusion protein. Glutathione (GSH)-Sepharose (Promega) beads (20 ml of a 50% slurry in NETN) were added, and the mixtures were incubated at 48C for 30 min with rocking. The beads were extensively washed with NETN and the bound proteins were subjected to electrophoresis on 12% polyacrylamide SDS gels. Electrophoresed proteins were ®xed in the gel and gels were soaked in Auto¯uor (National Diagnostics), dried, and exposed to Kodak X-AR ®lm with intensifying screens. Quantitation of the bound proteins was done either by densitometry (for dMax or Max) or by direct counting of the radiolabeled material in the bands. In the latter case, the appropriate bands were excised from the gels and soaked in 300 ml of dH 2 O for 15 min, followed by addition of scintillation cocktail (Ecoscint H, National Diagnostics) and counting. Numbers for bound protein are expressed as a percentage of the radiolabeled material seen in a band resulting from 1 ml of the appropriate in vitro translation product electrophoresed alongside the pull down reaction lanes.
Protein immunoblot (Western) analyses
Nuclear protein extracts prepared in radioimmunoprecipitation assay buer (RIPA: 10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS) were separated by electrophoresis on 12% polyacrylamide SDS gels, transferred to Immobilon-P PVDF membrane and immunoblotted with Max-speci®c antibodies at 1 : 1000 dilution as described . Bound antibodies were detected using enhanced chemiluminescence according to Matthews et al. (1985) .
Fluorescence assay for apoptosis
Quantitation of apoptotic cells was performed as described previously Hinoshita et al., 1992; Wu et al., 1996) . Brie¯y, cells were washed in cold PBS and resuspended in 1.5 ml of hypotonic¯uorochrome solution containing 5.0 mg/ml propidium iodide (PI, Sigma), 1% sodium citrate, and 0.1% Triton X-100 and analysed in a Becton Dickinson FACScan¯ow cytometer, with cell collection performed on log scale. Cells undergoing DNA fragmentation and apoptosis were shown to be weaker in PI¯uorescence than those in the typical G 0 /G 1 cell cycle.
